Tuberculosis Prevention for HIV Infected Adults

NCT00057122 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1148

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
Tuberculosis

Interventions

DRUG: Isoniazid
DRUG: Rifapentine
DRUG: Rifampin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)